GeneralConnection.com ➔ Dictionary
Dictionary Search

dianthus

Synonyms

Noun

1. Dianthus

2. genus Dianthus, caryophylloid dicot genus

Usage
Dianthus CIDP Data Lift Prospects While Funding And Dilution Risks Linger - Yahoo Finance
Dianthus (DNTH) SVP uses 10b5-1 plan to sell 30,000 shares - Stock Titan
Dianthus Therapeutics (DNTH) Stock After CAPTIVATE Results Looks Fairly Valued - simplywall.st
Add Spicy-Scented Dianthus to Your Garden with These Essential Tips - Better Homes & Gardens
Dianthus drops as Sanofi halts late-stage trial for CIDP therapy on efficacy concerns - MSN
Wells Fargo Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $135 - Moomoo
DNTH Shares Surge 89% Over the Past Six Months: What's Driving It? - TradingView
Dianthus Therapeutics: Sanofi's CIPD Study Fail Poses Uncomfortable Questions - Seeking Alpha
Genotoxic potential of Dianthus superbus var. superbus and Petasites paradoxus (Retz.) Baumg. methanolic extracts in Chinese hamster ovary cells - Nature
Dianthus offers up to $1B for China biotech's autoimmune 'pipeline in a product' - Fierce Biotech
[144] Dianthus Therapeutics, Inc. /DE/ SEC Filing - Stock Titan
Dianthus Therapeutics Inc (DNTH): FDA Makes Trials Easier - Yahoo Finance
Will Orphan Drug Status And Advancing Autoimmune Pipeline Change Dianthus Therapeutics' (DNTH) Narrative - Yahoo Finance
Dianthus Therapeutics (DNTH) details interim Phase 3 CIDP results, Phase 2 gMG data and $1.2B runway - Stock Titan
Dianthus Therapeutics (DNTH) Appears Attractive Amid Solid Product Pipeline - Yahoo Finance
Dianthus Therapeutics (DNTH) Is Up 30.8% After Upsized Raise And Early Phase 3 “Go” Decision - Yahoo Finance
Dianthus Therapeutics, Inc. (DNTH) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Kathy's Gardening Guide: Dianthus - The Ponte Vedra Recorder
Why Is Dianthus Therapeutics Stock Trading Higher On Friday? - Dianthus Therapeutics (NASDAQ:DNTH) - Benzinga
Why is Dianthus Therapeutics stock plunging today? - Investing.com
Evaluating Dianthus Therapeutics (DNTH) Valuation After A Strong Year Of Share Price Gains - Yahoo Finance
Raymond James reiterates Dianthus stock Strong Buy on competitor setback - Investing.com
Dianthus Therapeutics stock falls on Sanofi CIDP trial halt - Investing.com
PlantHaven International and Green Fuse Botanicals partner to expand Whetman dianthus portfolio in North America - Greenhouse Management
Biotech Dianthus hands new hires 60,000 stock options at $89.45 - Stock Titan
Dianthus Therapeutics to Participate in Two Investor Conferences - Yahoo Finance
Biopharma bites: Salspera's IPO plans, plus $600M+ raises for Xenon, Dianthus - FirstWord Pharma
Assessing Dianthus Therapeutics (DNTH) Valuation After FDA Trial Shift And Renewed Analyst Optimism - Yahoo Finance
Dianthus Therapeutics (DNTH) EVP sells 26,530 shares after option exercises - Stock Titan
How Does Dianthus Breeding Work? From the Breeder’s Lab to the Growers - Thursd
Guggenheim reiterates Dianthus stock rating citing potency edge - Investing.com
Dianthus' gMG prospect blooms, with phase 2 win setting up pivotal plans - Fierce Biotech
Dianthus Therapeutics Down Over 9%, On Track for Largest Percent Decrease Since January 2025 -- Data Talk - Moomoo
Dianthus Therapeutics: A Financed Autoimmune Platform With More Than One Way To Win (NASDAQ:DNTH) - Seeking Alpha
Dianthus to develop experimental therapy DNTH212 for Sjögren’s - Sjogren's Disease News
Dianthus Therapeutics, Inc. (DNTH) Stock Jumps 12.0%: Will It Continue to Soar? - Yahoo Finance
Dianthus Therapeutics (DNTH) Is Down 10.0% After FDA Eases Claseprubart Trials And Grants Orphan Status - simplywall.st
Dianthus Therapeutics stock rating maintained at Buy by TD Cowen - Investing.com
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish - The Motley Fool
Assessing Dianthus Therapeutics (DNTH) Valuation After FDA Eases Claseprubart Trial Screening Rules - Sahm
Guggenheim Reiterates Buy Rating for Dianthus Therapeutics (DNTH) - Yahoo Finance
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength? - Yahoo Finance
Dianthus Therapeutics posts interim CAPTIVATE responder data; 75% response in first 40 CIDP patients - TradingView
Dianthus Therapeutics closes $719M public offering - Investing.com
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results - Yahoo Finance
Why This Small Sanofi Rival Has Climbed 12-Fold Over Two Years - Investor's Business Daily
Dianthus got 20 responders before 40 patients in CIDP trial - Stock Titan
Assessing Dianthus Therapeutics (DNTH) Valuation After LBL-047 Autoimmune Focus Partnership And Capital Raise - Yahoo Finance
Dianthus Therapeutics CFO Sells $9.5 Million in Stock - The Motley Fool
Dianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Dianthus Therapeutics Announces Pricing of $625 Million Upsized Public Offering of Common Stock - Quiver Quantitative
Dianthus Therapeutics Conference: DNTH Eyes Q2 2026 CIDP Phase 3 Interim Readout, Expands Pipeline Plans - Yahoo Finance
UCB says Bimzelx tops Skyrizi in trial; Xenon, Dianthus set share sales - Endpoints News
Dianthus Therapeutics: Go Decision For CIDP Program Warrants Continued Buy Rating (DNTH) - Seeking Alpha
Dianthus in the pink as claseprubart CIDP phase III Captivates - BioWorld News
Dianthus Therapeutics' (DNTH) CFO Sold 8,224 Shares for $739,000 - The Motley Fool
Biotech Dianthus raises $719M to push autoimmune disease drugs - Stock Titan
Dianthus Therapeutics 10-K: $2.0M Revenue, $(4.20) EPS, widening net loss - TradingView
A new edition of Dianthus Week to bloom in Colombia - FloralDaily
Dianthus plans $400M share sale to fund autoimmune drug trials - Stock Titan
Dianthus Therapeutics stock hits 52-week high at 90.2 USD - Investing.com
Dianthus rises on proposed $400 million underwritten public offering - The Pharma Letter
Why This Biotech, Up 47% In Four Weeks, Just Surged Again - Investor's Business Daily
Leads Biolabs joins a $1B development deal with Dianthus - BioWorld News
Dianthus Therapeutics Initiates Licensing Agreement for DNTH212, a Promising Treatment for Autoimmune Diseases with Unique Mechanism of Action | DNTH Stock News - Quiver Quantitative
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally - The Motley Fool
Why is Dianthus Therapeutics stock plunging today? By Investing.com - Investing.com South Africa
New gMG contender emerges as Dianthus' claseprubart looks headed for Phase III - FirstWord Pharma
Dianthus Therapeutics Inc (DNTH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Dianthus Therapeutics Inc (DNTH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Dianthus gives 8 new employees stock options at $84.56 a share - Stock Titan
Six new Dianthus hires get options to buy 135,000 shares - Stock Titan
Fierce Pharma Asia—High-dollar licensing deals; Takeda's AI drug design pact; and the finale of Novo vs. KBP - Fierce Pharma
“A long-term strategy to promote Colombian Dianthus around the world” - FloralDaily
Dianthus Therapeutics Inc (DNTH) Institutional Confidence - TradingKey
Dianthus Therapeutics stock hits 52-week high at 46.6 USD - Investing.com
Dianthus Therapeutics Closes $288 Million Public Offering to Advance Clinical Development of Antibody Therapeutics - Quiver Quantitative
Dianthus CFO Sells 20,000 Shares for $903,600 After Massive Year-End Run - The Motley Fool
Dianthus (DNTH) director Jonathan Violin receives grant of 6,090 stock options - Stock Titan
NanoTemper Strengthens Biopharma Discovery Portfolio with Acquisition of Envue Technologies and Launch of Dianthus™ α - PR Newswire
Dianthus’ selective complement inhibitor yields Phase 2 success in myasthenia gravis - Endpoints News
Dianthus Therapeutics stock maintained at Buy by TD Cowen - Investing.com
Dianthus to take gMG mAb to Phase III after mid-stage win - Clinical Trials Arena
Dianthus Therapeutics stock hits 52-week high at 88.35 USD - Investing.com
Raymond James reiterates Dianthus stock Strong Buy on competitor setback By Investing.com - Investing.com Australia
In an Alpine Plant Species, Ancient Alleles May Help Drive Climate Change Adaptation - State of the Planet
William Blair reiterates Dianthus stock rating on CIDP trial data - Investing.com
Dianthus prices $625M stock offering at $81 per share - Investing.com
Dianthus Therapeutics Reports Positive Phase 2 MaGic Trial Data for Claseprubart in Generalized Myasthenia Gravis and Plans Phase 3 Trial Initiation in 2026 | DNTH Stock News - Quiver Quantitative
Dianthus Therapeutics' (DNTH) CFO Sold 8,224 Shares for $739,000 - Yahoo Finance
Dianthus inks licensing deal with Chinese biotech; C4 targets $125M offering - Endpoints News
Surge in Dianthus Therapeutics Stock Amid Positive Trial Results - StocksToTrade
Dianthus Therapeutics’ CAPTIVATE Trial Sparks Renewed Investor Interest - timothysykes.com
Guggenheim’s Bold Move: Price Target for Dianthus Doubles to $200 - timothysykes.com
Dianthus, Opendoor, and More Stocks See Action From Activist Investors - Barron's
Guggenheim Doubles Price Target for Dianthus: A Promising Future? - timothysykes.com
Plant These Two Flowers Together In October For A Hummingbird-Filled Garden In Spring - House Digest
Cottage Pinks: Add Spice to Flower Borders - The Spruce
How to Keep Carnations Fresh and Long-Lasting - Thursd
We Think Dianthus Therapeutics (NASDAQ:DNTH) Can Afford To Drive Business Growth - simplywall.st
Foreign Language Equivalents
Foreign Language Equivalents of 'dianthus'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
diianthus,   diaanthus,   idanthus,   diannthus,   duanthus,   disnthus,   dianths,   diatnhus,   sianthus,   diantus,   diamthus,   ddianthus,   dianthis,   doanthus,   dianthuus,   diantuhs,   ianthus,   dianthsu,   diabthus,   diantjus,   dinathus,   dianthua,   diantgus,   diathus,   diantthus,   dianyhus,   dainthus,   dianthud,   dianthhus,   dianthuss,   dianhtus,   dianthu,   fianthus,   dinthus,   danthus,   dianthys,   dianhus,   dianrhus
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z